Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Vues
• 08/04/23
0
0
Intégrer
administrator
Les abonnés
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires